We are live on ! Find out more
SRIM

Saratoga Research & Investment Management Portfolio holdings

AUM $1.83B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
+3.03%
1 Year Est. Return
+18.41%
3 Year Est. Return
+54.35%
5 Year Est. Return
+69.05%
10 Year Est. Return
+285.04%
AUM
$1B
AUM Growth
+$23.3M
Cap. Flow
-$786K
Cap. Flow %
-0.08%
Top 10 Hldgs %
46.78%
Holding
57
New
3
Increased
22
Reduced
17
Closed
1

Top Sells

Rank Stock Value
1
ABT icon
Abbott
ABT
+$16.4M
2
NVO
Novo Nordisk
NVO
+$2.58M
3
MMM icon
3M
MMM
+$2.33M
4
JNJ icon
Johnson & Johnson
JNJ
+$1.69M
5
NKE icon
Nike
NKE
+$1.55M

Sector Composition

Rank Sector Weight
1 Technology 28.29%
2 Healthcare 19.73%
3 Consumer Staples 17.2%
4 Industrials 16.48%
5 Consumer Discretionary 8.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
K
51
DELISTED
Kellanova
K
$297K 0.03%
4,819
GE icon
52
GE Aerospace
GE
$379B
$260K 0.03%
+2,066
New +$263K
XOM icon
53
ExxonMobil
XOM
$657B
$239K 0.02%
+2,377
New +$240K
NVS icon
54
Novartis
NVS
$290B
$230K 0.02%
2,840
DD icon
55
DuPont de Nemours
DD
$19.5B
$201K 0.02%
+1,540
New +$196K
ABT icon
56
Abbott
ABT
$192B
-425,052
Closed -$16.4M

Similar funds

Saratoga Research & Investment Management's Q2 2014 Portfolio in Review

As of Q2 2014, Saratoga Research & Investment Management held 57 positions worth $1B, up 2.4% from $981M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Saratoga Research & Investment Management's Q2 2014 filing shows 3 new, 22 increased, 17 reduced and 1 closed positions. Its largest new stake was GE Aerospace: 2,066 shares worth $260K. The largest sale was Abbott, an estimated $16.4M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Saratoga Research & Investment Management's largest Q2 2014 buy was GE Aerospace: 2,066 shares worth $260K.
  • Saratoga Research & Investment Management added most to Varian Medical Systems, Inc. in Q2 2014, an estimated $3.68M increase.
  • Saratoga Research & Investment Management's biggest Q2 2014 reduction was Novo Nordisk, cutting an estimated $2.58M.
  • Saratoga Research & Investment Management fully exited Abbott in Q2 2014, selling an estimated $16.4M.
  • Saratoga Research & Investment Management's ten largest holdings make up 47% of its $1B portfolio in Q2 2014.
  • Saratoga Research & Investment Management opened 3 new positions and closed 1 in Q2 2014.
  • Saratoga Research & Investment Management's portfolio value rose 2.4% quarter-over-quarter to $1B.

Based on Saratoga Research & Investment Management's 13F filing for Q2 2014, filed 6 Aug 2014.